Clinical Trial Update: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb) [Phase 2]

View source ↗

Summary

A Phase IIb trial evaluating allogeneic ABCB5-positive dermal mesenchymal stromal cells for chronic venous ulcers has completed treatment activity/status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Insufficiency
• Venous Leg Ulcers

Drugs mentioned

• ABCB5-positive dermal mesenchymal stromal cells (ABCB5-positive dermal mesenchymal stromal cells)

Snippet

Sponsor: RHEACELL GmbH & Co. KG | Conditions: Skin Ulcer Venous Stasis Chronic | Phase 2 | Status: COMPLETED